Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) EBIT: 2010-2025

Historic EBIT for Neogen (NEOG) over the last 15 years, with Aug 2025 value amounting to -$16.1 million.

  • Neogen's EBIT fell 812.94% to -$16.1 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$1.1 billion, marking a year-over-year decrease of 2683.09%. This contributed to the annual value of -$1.1 billion for FY2025, which is 1908.63% down from last year.
  • Latest data reveals that Neogen reported EBIT of -$16.1 million as of Q3 2025, which was up 97.37% from -$611.2 million recorded in Q2 2025.
  • In the past 5 years, Neogen's EBIT ranged from a high of $23.4 million in Q2 2023 and a low of -$611.2 million during Q2 2025.
  • For the 3-year period, Neogen's EBIT averaged around -$89.0 million, with its median value being $12.0 million (2024).
  • Its EBIT has fluctuated over the past 5 years, first spiked by 288.94% in 2023, then crashed by 4,787.00% in 2025.
  • Over the past 5 years, Neogen's EBIT (Quarterly) stood at $12.5 million in 2021, then crashed by 161.40% to -$7.7 million in 2022, then skyrocketed by 288.94% to $14.5 million in 2023, then tumbled by 3,262.70% to -$457.5 million in 2024, then crashed by 812.94% to -$16.1 million in 2025.
  • Its last three reported values are -$16.1 million in Q3 2025, -$611.2 million for Q2 2025, and $5.4 million during Q1 2025.